Concord Drugs Q3 Results

  • BSE: 538965
  • NSE: -
  • ISIN: INE858L01010
  • Sector: Biotechnology & Drugs
BSE
34.75-1.25 (-3.47%)
Volume12.68 K
Updated: Tue 26 Nov, 2024 | 15:29:55
NSE
This stock is not traded on NSE
Today: 33.94
37.90
52-Wk: 30.59
61.50

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Concord Drugs Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 12.787.52-%13.53-%
    Selling/ General/ Admin Expenses Total 1.541.46-%1.31-%
    Depreciation/ Amortization 0.390.39-%0.38-%
    Other Operating Expenses Total 0.490.36-%1.07-%
    Total Operating Expense 12.546.30-%12.46-%
    Operating Income 0.241.22-%1.06-%
    Net Income Before Taxes -0.260.80-%0.62-%
    Net Income -0.240.56-%0.45-%
    Diluted Normalized EPS -0.240.60-%0.52-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts